The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stryker recently unveiled its T2 Alpha Humerus Nailing System, expanding its orthopedic offerings. The company also initiated a limited market release for its Mako RPS handheld robotic system, designed for total knee replacement procedures. This innovative Mako RPS system is expected to significantly broaden the application of robotic-assisted knee surgeries. Concurrently, Stryker reported robust financial performance for the full year 2025. The medical device giant achieved total sales of US$25.12 billion and a net income of US$3.25 billion. These strategic product introductions, coupled with strong earnings, reinforce Stryker's leadership in orthopedic robotics and signal a positive outlook for its future growth.
Sign in to access this content
Sign In